- Home
- Blog
- News
- Basics
- Sources
- Agencies, Regulatory & Organisations
- CERSI Excipients Browser
- Excipient Report
- Excipient DMF List
- EXCiPACT Certified Companies
- Excipient Documentation
- Excipient EINECS Numbers
- Excipient E-Numbers
- FDA Inactive Ingredient List
- FDA GRAS Substances (SCOGS) Database
- IPEC Americas
- USP - U.S. Pharmacopeia
- Definitions
- Whitepapers / Publications
- Supplier
- Services
- Media
- Events
- 1st pharmaexcipients Poster Award
- Event Calendar
- Events featured by pharma-excipients
- 4th Annual Formulation & Drug Delivery Congress
- DDF Summit
- ExcipientFest Americas
- ExcipientFest Asia
- Global CompliancePanel
- International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
- Formulation & Drug Delivery USA Congress
- Laboratory Medicine 2018
- Making Pharmaceuticals Europe
- Making Pharmaceuticals Exhibition
- Pharma Integrates
- PharmaExcipients China @CPhI China
- TTC Technology Training Center
- Jobs
- Online Sourcing
- Contact
05. July 2016
NEWS RELEASE - Brussels, 5th July, 2016 The Board of EXCiPACT asbl is pleased to announce that, as required by the rules of the independent EXCiPACT Certification Scheme for manufacturers and distributors of pharmaceutical grade excipients operational since 2013, the triennial reregistration of the Scheme’s Certifying Bodies, Auditors and the recertification of Certificate Holders, has successfully begun.
01. March 2016
By Phil Taylor, 01-Mar-2016 Three years since it was set up, excipient certification organisation EXCiPACT is expanding beyond its European heartland to other areas of the world. More
05. October 2015
As EU supplier risk assessment deadlines approach, a number of voluntary third-party auditing and certification options are available. Will more excipient suppliers, and drug manufacturers, use them? More
19. September 2015
The IPEC Federation believes that independent, third party auditing and certification of excipient suppliers can assist in the development, manufacture and supply of safe and effective medicinal products. The use of third party audit and certification programmes helps to reduce costs, time and resources of both excipient suppliers and users. Such third party audit and certification schemes both raise quality expectations to an industry-accepted level and enhance patient safety. More
01. July 2015
MUMBAI, India--(BUSINESS WIRE)--IDEAL CURES PVT. LTD. is delighted to announce that it has received third EXCiPACT™ certificate for its manufacturing site located at Vasai. The plant at Vasai is the main manufacturing facility of the company and has received EXCiPACT™ certification for Film Coating Materials (INSTACOAT™, INSTANUTE™, INSTASPRAY™, and INSTAMASK™) and Extended Cooling Boosters (ECOCOOL™). With receipt of this third certificate all manufacturing plants of Ideal Cures...
04. May 2015
EXCiPACT asbl is delighted to announce that Ideal Cures Pvt.Ltd. of India has recently been awarded two EXCiPACT™ Certificates from SGS France, one of EXCIPACT’s internationally-recognised Certification Bodies. http://www.excipact.org/publication-items/28-apr-2015-ideal-cures-pvt-ltd-is-the-first-indian-company-to-receive-excipact-certification-as-pharmaceutical-excipient-suppliers/